Etirinotecan pegol Target-Specific Pharmacodynamic (PD) Biomarkers Measured in Circulating Tumor Cells (CTCs) from Patients in the Phase 3 BEACON Study in Patients with
American Society of Clinical Oncology
Announcing the Institute@Precision, a Collaborative Forum for Biopharma Innovation.
Peer-reviewed articles and conference poster presentations
Poster
Download Poster
Poster
Download Poster
Research Article
Download Article
Research Article
Download Research Article
Research Article
Download Research Article
Poster
Download Poster
Poster
Download Poster
Poster
Download Poster